Eric Martin
15Patents
5h-index
43Co-inventors
66Inventor score
Filing activity: Jul 30, 1993 → Sep 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5480871A | Peptoid .alpha.-1 adrenergic receptor ligands | Physics | 12 | Expired |
| US5536853A | Opiate receptor ligands | Human Necessities | 12 | Expired |
| US5447916A | Peptoid alpha-1 adrenergic receptor ligands | Physics | 12 | Expired |
| US6689879B2 | Modified HIV Env polypeptides | Chemistry; Metallurgy | 11 | Expired |
| US7662581B1 | Eg5 co-crystals | Physics | 9 | Expired |
| US5605932A | Opiate receptor ligands | Chemistry; Metallurgy | 4 | Expired |
| US7576221B2 | Substituted imidazole derivatives | Chemistry; Metallurgy | 3 | Expired |
| US5481020A | Opiate receptor ligands | Chemistry; Metallurgy | 2 | Expired |
| US8318791B2 | Substituted imidazole derivatives | Chemistry; Metallurgy | 1 | Active |
| US6121240A | Urokinase receptor ligands | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5747458A | Urokinase receptor ligands | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8735599B2 | Substituted imidazole derivates | Chemistry; Metallurgy | 0 | Active |
| US5536868A | Opiate receptor ligands | Chemistry; Metallurgy | 0 | Expired |
| US7820646B2 | Cyclized derivatives as Eg-5 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7662916B2 | Modified HIV Env polypeptides | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.